SCHEMBL1577584

SCHEMBL1577584

Fc1ccc2c(nc(-c3cccnc3Cl)n2Cc2cccc(Cl)c2)c1F

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.53
SMN1; SMN2 Q16637 3/20 0.53
CYP1A2 P05177 2/20 0.53
CYP2C9 P11712 2/20 0.53
CYP2C19 P33261 2/20 0.53
NPSR1 Q6W5P4 4/20 0.51
KMT2A Q03164 3/20 0.47
MEN1 O00255 1/20 0.47
CYP2D6 P10635 1/20 0.47
ALDH1A1 P00352 3/20 0.45
GAA P10253 2/20 0.45
RECQL P46063 1/20 0.45
RCE1 Q9Y256 1/20 0.43
HPGD P15428 3/20 0.43
HTT P42858 2/20 0.43
TDP1 Q9NUW8 1/20 0.43
LMNA P02545 5/20 0.42
HTR6 P50406 3/20 0.42
IDO1 P14902 1/20 0.39
PTGDR2 Q9Y5Y4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1577021 0.91 KDM4E (0.63) KDM4ESMN1; SMN2CYP1A2CYP2C9CYP2C19
SCHEMBL1482932 0.84 KDM4E (0.60) KDM4ESMN1; SMN2CYP1A2CYP2C9CYP2C19
SCHEMBL1577440 0.82 FFAR4 (0.38) KDM4ESMN1; SMN2CYP1A2CYP2C9CYP2C19
SCHEMBL1577206 0.79 CCR2 (0.41) KMT2ARCE1HTR6GRIN1GRIN2B
SCHEMBL1577106 0.79 KDM4E (0.47) KDM4ESMN1; SMN2CYP1A2CYP2C9CYP2C19
SCHEMBL1577408 0.77 DHFR (0.41) NPSR1KMT2ARCE1LMNAHTR6
SCHEMBL1577424 0.76 DHFR (0.40) KMT2ARCE1HTR6
SCHEMBL1577199 0.76 NPSR1 (0.40) KDM4ESMN1; SMN2CYP1A2CYP2C9CYP2C19
SCHEMBL1577485 0.76 KMT2A (0.46) KDM4ESMN1; SMN2CYP1A2CYP2C9CYP2C19
SCHEMBL1484226 0.74 KDM4E (0.72) KDM4ESMN1; SMN2CYP1A2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2483247-A1 NEW BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. Hoffmann-La Roche AG (CH) 2012-08-08 EP disclosed
WO-2011039130-A1 NEW BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2011-04-07 WO disclosed